Genital Herpes (HSV-2) in Black Men: Signs on Dark Skin

On brown and black skin, a genital herpes outbreak usually does not look red. The inflammation textbooks call erythema shows up as violaceous, gray, or brown, and a 2025 review in Cureus found clinicians trained to look for redness routinely miss it in darker skin. That mismatch costs men diagnoses. About 8.2% of US men aged 14 to 49 carry HSV-2, and most were never told. It is a skin virus with a treatment, not a verdict on your character.

The sequence is the same on every skin tone. Only the color changes. It opens with a prodrome, a localized tingling, itching, or burning about 12 to 24 hours before anything is visible. Small blisters then appear in a tight cluster, not scattered singly. They break into shallow ulcers, which dry and crust before the skin closes. A first episode runs 2 to 3 weeks untreated; recurrences are shorter, usually 5 to 10 days, and heal without scarring.

Here is where the standard description fails. Nearly every clinical image of herpes shows blisters on a red base, because those images were made on white skin. On skin with more melanin that base is not red. It reads as violaceous, gray, or brown, sometimes as nothing more than a patch a shade or two darker than the skin around it. Scan for redness and you will scan straight past it. Look for the pattern instead: a tight group of small fluid-filled bumps, a change in tone, and the tingling that came first.

The aftermath confuses as much as the outbreak. Darker skin frequently leaves post-inflammatory hyperpigmentation, flat dark marks where the lesions were, which follows inflammation more often and more severely in darker skin. Those marks are not scars and not an active outbreak. Herpes heals without scarring, so a flat dark patch weeks later is pigment. It fades over weeks to months, which is why men think an outbreak lasted far longer than it did.

Location follows the nerve. In men, lesions most often appear on the glans, the shaft of the penis, or the foreskin. HSV-2 lives in the sacral nerve roots, so outbreaks and shedding can occur anywhere that nerve group serves: the scrotum, groin, perianal area, buttocks, and upper thighs. A recurring cluster on one buttock or the back of a thigh is a classic HSV-2 pattern.

Razor bumps and folliculitis. Pseudofolliculitis barbae, the reaction to a shaved hair curving back into the skin, affects an estimated 45% to 80% of men of African ancestry and occurs anywhere hair is shaved, including the pubic area. Razor bumps center on individual follicles where you shave; herpes arrives as a tight cluster of blisters preceded by tingling. Herpes can also infect follicles directly and lack the classic blisters, so a groin rash that fails antibacterial or antifungal treatment should raise a viral cause.

A syphilis chancre. Memorize this one, because the treatment is completely different. Primary syphilis makes a single, well-demarcated ulcer with a clean base and a firm indurated border, and it is painless. Herpes ulcers are typically multiple, shallow, preceded by tingling, and they hurt. The painless sore is the more dangerous one. So the answer is not to get better at looking. Looking is not a diagnosis. A PCR swab of an active sore names the virus and types it.

Three things stack. HSV-2 is less common in men, 8.2% against 15.9% of women in the 2015-2016 national survey, and symptomatic recurrences are less frequent in men, so there is less to notice. Men also have fewer encounters where it would surface: national data show men significantly less likely than women to get routine checkups, largely because they have fewer visits at all.

Third, and most articles get this wrong: the US Preventive Services Task Force recommends against routine blood screening for genital herpes in people without symptoms, a grade D recommendation reaffirmed in 2023. The available tests throw off enough false positives in low-symptom populations that the Task Force judged the harms to outweigh a small benefit. So the honest advice is not to demand an IgG. Testing is warranted when there is a reason: symptoms, unexplained recurring sores, a partner with known HSV, a planned pregnancy, or living with HIV. The recommendation explicitly excludes all of those. Our guide to what a standard STI panel covers and skips shows where herpes sits in a full workup.

The result is a large population of men carrying a manageable virus with no idea. In NHANES data analyzed in 2010, 85.5% of people who tested positive for HSV-2 had never been told, and among Black participants that figure was 91.5%. The authors found the gap was not explained by education, income, region, or insurance, and pointed at how rarely anyone is tested. Roughly 20% of undiagnosed infections are truly symptom-free; the rest have symptoms mild enough to blame on something else.

Two notes on those numbers. They come from blood drawn in a representative national sample, so they measure infection, not diagnoses reported to a health department. And where researchers have asked why STI rates differ between groups, the answer has not been behavior: a network analysis found the differences were explained by the structure of sexual networks, not by what people do inside them.

HSV-2 is not only a nuisance on its own. A meta-analysis of longitudinal studies found men with existing HSV-2 had about 2.7 times the risk of acquiring HIV if exposed, holding after adjustment for age and sexual behavior. Herpes brings the immune cells HIV targets to the genital surface and breaks the skin barrier, including during the frequent stretches of shedding when nothing is visible.

There is a concrete step attached to that number. Knowing you have HSV-2 gives you a documented reason to ask about PrEP, the pill or injection that cuts the risk of getting HIV from sex by about 99% when taken as prescribed. Our guide to PrEP for Black Americans covers the ask.

There is no cure, and the infection does not get worse over time. Antivirals shorten an outbreak when started at the first sign, and taken daily as suppressive therapy they prevent most outbreaks outright. Standard regimens are valacyclovir 500 mg once daily, acyclovir 400 mg twice daily, or famciclovir 250 mg twice daily, with valacyclovir 1 g daily for very frequent recurrences.

The reason to consider it even when your outbreaks are mild is what it does for someone else. In a randomized trial of 1,484 couples where one partner had HSV-2, once-daily valacyclovir dropped acquisition in the uninfected partner from 3.6% to 1.9% over eight months. Condoms and avoiding sex during an outbreak drop it further. Our companion piece on HSV-2 in Black women covers blood testing and pregnancy.

Short, factual, before sex, not during an outbreak. You have HSV-2. It is a common skin virus. You take a daily pill that cuts the chance of passing it on by about half, and you use condoms. That is the whole conversation, and you do not owe an apology for it.

Bring specifics. With a sore right now, ask for a PCR swab of the lesion typed for HSV-1 versus HSV-2, plus syphilis serology at the same visit, since the two look alike and the treatments differ. With recurring outbreaks or a partner to protect, ask about daily suppressive valacyclovir by name. You can find a Black primary care clinician or urologist in our directory.